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The cag pathogenicity island (cag-PAI) is one of the major virulence determinants of Helicobacter pylori. The 
chromosomal integrity of this island or the lack thereof is speculated to play an important role in the progress 
of the gastroduodenal pathology caused by H. pylori. We determined the integrity of the cag-PAI by using 
specific flanking and internally anchored PCR primers to know the biogeographical distribution of strains 
carrying fully integral cag-PAI with proinflammatory behavior in vivo. Genotypes based on eight selected loci 
were studied in 335 isolates obtained from eight different geographic regions. The cag-PAI appeared to be 
disrupted in the majority of patient isolates throughout the world. Conservation of cag-PAI was highest in 
Japanese isolates (57.1%). However, only 18.6% of the Peruvian and 12% of the Indian isolates carried an intact 
cag-PAI. The integrity of cag-PAI in European and African strains was minimal. All 10 strains from Costa Rica 
had rearrangements. Overall, a majority of the strains of East Asian ancestry were found to have intact cag-PAI 
compared to strains of other descent. We also found that the cagE and cagT genes were less often rearranged 
(18%) than the cagA gene (27%). We attempted to relate cag-PAI rearrangement patterns to disease outcome. 
Deletion frequencies of cagA, cagE, and cagT genes were higher in benign cases than in isolates from severe 
ulcers and gastric cancer. Conversely, the cagA promoter and the left end of the cag-PAI were frequently 
rearranged or deleted in isolates linked to severe pathology. Analysis of the cag-PAI genotypes with a different 
biogeoclimatic history will contribute to our understanding of the pathogen-host interaction in health and 
disease. 
Infection with Helicobacter pylori has plausible associations 
with a variety of clinical outcomes. This includes chronic gas-
tritis, duodenal ulcer, gastric cancer, lymphomas and seemingly 
paradoxical relationships with gastroesophageal reflux disease 
and adenocarcinoma of the gastric cardia (12, 13, 15, 29, 38). 
H. pylori inhabits at least 50% of the world's population, with 
the highest incidence recorded in industrially underdeveloped 
areas, including Asia (70 to 80%) and Africa (70 to 90%), and 
a waning occurrence in developed areas such as North Amer-
ica (30 to 40%), South America (80 to 90%), and Europe (30 
to 70%) (33). Prevalence rates vary between populations and 
between groups within the same population (49). 
Variation in the clinical outcome of H. pylori induced pa-
thology is multifactorial, involving a complex interplay between 
the host immune responses, pathogen virulence factors, and 
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niche characteristics. Many putative virulence factors have 
been identified in H. pylori that contribute to its pathogenesis. 
Most important among them are the 128-kDa cytotoxin-asso-
ciated gene-encoded antigen gene (cagA) (18, 45) and the 
vacuolating cytotoxin antigen gene (vacA) (4, 43). The cagA 
gene is present downstream of an —40-kb cluster of virulence 
genes known as the cag pathogenicity island (cag-PAI) located 
at the 3' end of the glutamate racemase gene. In some strains, 
the presence of an insertion element 15605 may disrupt an 
otherwise-uninterrupted unit into two regions, cag I and cag II, 
consisting of at least 14 and 16 open reading frames (ORFs), 
respectively (11). These genes encode a type IV secretion sys-
tem that forms a syringe-like structure to translocate the im-
munodominant cagA protein into the gastric epithelial cells. 
cag-PAI has also been implicated in the induction of interleu-
kin-8 (IL-8) in cultured gastric cells. As shown by the system-
atic mutagenesis studies of individual genes encoding the cag-
P AI, there are at least 17 of 27 genes that are found to be 
essential for translocation of cagA into host cells (syringe-like 
function), and 14 were necessary for H. pylori to fully induce 
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transcription of IL-8 (17). This property contributes to the 
proinflammatory power of the strains and thus also to its vir-
ulence capability. Nevertheless, the induction of IL-8 is not 
exclusively linked to cag-PAL Exposure of gastric epithelial 
cells to cag-PAI-positive H. pylori can activate the proto-onco-
genes c-fos and c-jun, a crucial step in the development of H. 
pylori-related neoplasia (30). An intact cag-PAI has therefore 
been thought to contribute toward full proinflammatory power 
of H. pylori. However, the island has proved to be prone to 
disruption due to various genetic rearrangements occurring 
within and outside the constituent genes. Further still, the 
impact of intactness or rearrangement of the island or the 
constituent genes on the progression of gastroduodenal pa-
thology has been debated. It has been argued that abolition of 
cagE gene results in a considerable reduction of IL-8 produc-
tion (2, 11, 14, 36, 38, 51), whereas strains capable of eliciting 
an IL-8 response irrespective of an intact cag-PAI have been 
described (23, 28). Some strains causing nonulcer dyspepsia 
have regions of the promoter of cagA gene deleted (28), al-
though this gene has long been regarded as a marker for the 
functionality of the cag-PAI. However, due to rearrangements 
often inhibiting cagA, it does not seem to be a reliable indicator 
of the virulence spectrum of strains (7). Other members of the 
cag-PAI have also been scrutinized for their involvement in 
virulence characteristics. The cagE gene served as a better 
marker of an intact cag-PAI in Japanese strains (22, 28) and 
French isolates (5). 
The cagG gene was shown to be a better indicator for the 
presence of an intact cag-PAI than the cagE gene in French 
isolates (41). Deletion of cagE, cagT, cagA, cagG, and cagM 
genes was reported in all cases of chronic gastritis, gastric ulcer 
and gastric cancer, indicating that the pathogenicity of H. pylori 
may not be determined by cag-PAI genes alone in such cases 
(24). In a series of patients from Taiwan, the presence of cagA, 
cagC, cagE, cagF, cagN, and cagT genes in the PAI showed no 
relationship to the type of disease and/or the histological fea-
tures present in the patients (46). The involvement of these 
genes and others in eliciting a strong immune response has also 
been contested (45). Rearrangements in cag-PAI in H. pylori 
isolates in different countries have been reported in isolation 
(5, 22, 23, 26, 28, 37, 40, 47). However, there are no compre-
hensive data available on the abundance of intact versus rear-
ranged cag-PAI in strains inhabiting geographically and cultur-
ally distinct patient populations on a global scale. Such data on 
geographical distribution of cag-PAI rearrangement patterns 
may provide a window into the trinity of bacterial virulence, 
host genetic predisposition, and niche characteristics in a bet-
ter way. These concerns, as well as our continued efforts (1, 9, 
10, 21) to study the complexities associated with the infection 
dynamics and evolutionary genetics of this interesting patho-
gen with regard to host-pathogen interactions at all levels, led 
to the inception of the present study. We have used here 
simple and nested PCR-based genotyping approaches to dem-
onstrate for the first time with a large number of strains that 
the cag-PAI is not perpetually intact in majority of H. pylori in 
the world. 
MATERIALS AND METHODS 
Patients and bacterial isolates. cag-PAI analyses were performed on a total of 
335 H. pylori DNAs obtained from patient isolates from eight different countries:  
Spain, Peru, South Africa, England, Ireland, Japan, Costa Rica, and India. These 
isolates were recovered from unrelated patients undergoing upper gastrointes-
tinal endoscopy after informed consent was obtained. Bacterial isolates were 
cultured from antral biopsies as described previously (I). Genomic DNA samples 
were prepared, quantified, and preserved according to the methods described 
elsewhere (1). Most of the strains we used were described in other studies, and 
their microbiological and clinical characteristics have been elaborated elsewhere 
(1, 9, 25, 35, 48). To remove biases, isolates were picked randomly based merely 
on geographic representation. Classification and tabulation based on clinical 
corroboration was attempted only after the experiments were completed. Iso-
lates including genomic DNA preparations belonging to patients from Peru, 
Spain, Japan, England, and South Africa were a gift from Asish Mukhopadhyay 
and Douglas E. Berg (Washington University, St. Louis, Mo.). Genomic DNAs 
from Irish H. pylori isolates were obtained from single antral gastric biopsies 
from patients experiencing peptic ulcer disease at the Meath-Adelaide and St. 
James's Hospitals in Dublin, Ireland. 
cag•PAI PCR analysis. PCR analyses were carried out with eight oligonucle-
otide pairs (Table 1) as described by Ikenoue et al. (22) to amplify five different 
loci spread over the cag I and cag II regions. The presence or absence of the gene 
cagA, the promoter regions of cagA, cagE, and cagT, and the left end of cag-PAI 
(LEC) was detected. All PCRs were performed in a total volume of 10 ul 
containing 0.25 p.l of genomic DNA (50 ng/a1), 10x PCR buffer (Applied 
Biosystems), 2 mM MgCl2 (MBI), 80 11M deoxynucleoside triphosphates (Am-
ersham Biosciences), 10 pM concentrations of each forward and reverse primer, 
and 1 U of Taq polymerase (Applied Biosystems). The total volume was made up 
with autoclaved Milli-Q water. H. pylori 26695 DNA was taken as a positive 
control. A negative control lacking either DNA or primers was also included. 
The absence of cag-PA1 was confirmed in isolates reported to be negative for the 
same by using previously described primers flanking the cag-PAI (11, 22, 25). 
Appropriate measures were taken to avoid contamination. PCR was performed 
in a 9700 thermal cycler (Applied Biosystems). Amplification conditions were 
optimized as follows: initial denaturation for 5 min at 94°C was followed by 40 
cycles of denaturation at 90°C for 30 s, annealing at 52°C for 30 s, and extension 
at 70°C for 1 min. After a final extension at 70°C for 10 min, the amplified 
products were resolved on a 1% agarose gel in lx TAE buffer (40 mM Tris-
acetate-1 mM EDTA [pH 8.0]) containing ethidium bromide (0.5 µg/ml) and 
then visualized under UV light. 
All of the cag-PAI rearrangement profiles generated in the present study were 
archived in the form of a searchable database (http://www.cdfd.org.in/amplibase 
/HP).  
RESULTS 
PCR amplification of cag-PAI regions. We determined in-
tactness or otherwise of the cag-PAI genes by using specific 
flanking and internally anchored PCR primers. This was es-
sentially to know the geographic prevalence of strains with 
different cag-PAI rearrangement patterns and whether these 
patterns could be associated with the clinical outcome of the 
infection. The reasons for spanning the entire cag-PAI region 
with eight specific PCR primers have been already explained 
elsewhere (28) based on Southern blot analysis and, more 
recently, by Ikenoue et al. (22). In our experiments, all of the 
PCR results were 100% reproducible on all occasions. All of 
the samples were independently tested at the Centre for DNA 
Fingerprinting and Diagnostics (CDFD) and the Deccan Col-
lege of Medical Sciences. Our results, upon crosschecking, 
were found to be the same within and between the two labs. 
PCR amplification protocols were portable and easy to per-
form. The PCR amplification procedure was tested on differ-
ent positive and negative control samples and also with paired 
isolates and serial isolates obtained from the same patients 
months apart. Overall, the PCR technique that we used was 
robust, reproducible, portable, easy to perform, and highly 
specific for the corresponding regions of the cag-PAI (Fig. 2). 
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TABLE 1. Details of the PCR primers used for rearrangement analysis within cag-PAI 
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Primer pairs Sequence Amplicon size (bp) Locus name 
Coordinates in 
HP26695 genome 
cagAF1 
cagAR1 
AACAGGACAAGTAGCTAGCC 
TATTAATGCGTGTGTGGCTG 
349 HP0547/JHP0495 582638-583137 
cagAF2 
cagAR2 
GATAACAGGCAAGC1-1 1 1GA 701 HP0547/JHP0495 580092-580440 
TCTGCCAAACAATCT1TTGCAG 
cagAP-F1 GTGGGTAAAAATGTGAATCG 730 Promoter region of 579697-580440 
cagAR2 
HP0547/JHP0495 
TCTGCCAAACAATC1 1 1 1GCAG 
cagAP-F2 CTACTTGTCCCAACCA1 1 1 1 1181 Promoter region of 579231-580440 
cagAR2 
HP0547/JHP0495 
TCTGCCAAACAATC1 1 1 1 GCAG 
cagEFl 
cagER1 
GCGATTGTTATTGTGCTTGTAG 
GAAGTGGTTAAAAAATCAATGCCCC 
329 HP0544/JHP0492 577492-579697 
cagTF1 
cagTR1 
CCATG1TTATACGCCTGTGT 
CCATGTTTATACGCCTGTGT 
301 HP0532/JHP0522 565171-565471 
LecFl ACA 1 1 1-1GGCTAAATAAACGCTG 384 JHP0521/JHP0522 547222-547242 
LecR1 TCTCCATGTTGCCATTATGCT 
LecF2 ATAGCGTTTTGTGCATAGAA 877 JHP0520/JHP521 
LecR2 ATCITIAGTCTCITTAGCTT 
° 	 Ikenoue et al. (22). 
For the strains with an incomplete or rearranged cag. PAI, 
PCRs were repeated for all of the regions to reconfirm the 
results. 
The percentage of PCRs positive for the cagE and cagT  
genes was always more (82%) than any other cag-PAI region 
studied (Fig. 1 to 3). These genes were more frequently intact 
compared to the cagA gene (72.8%). Deletions were frequently 
observed in the three ORFs located in the extreme left of the 
414.  
cagA 
LecF2 	 LecR2 
   
cagAF2 	 cayAFI 
<-1 r  
(„t=7 
ca;i4 P2 
I 	  < 1 
cagT F cagT R 
Eg> ,E31 
cagE F cagE R 
cagAP F I 
cagAP 
   
Region (Nos) Left end of cag-PAI 
LEC1 	 LEC2 
cagT cagE cagA Promoter 
P1 	 P2 
cagA2 cagA 1 Strains with intact 
cag-PAI 
Japan (28) 25 22 25 28 28 27 27 26 16 (57.1%) 
India (63) 36 29 49 51 26 15 44 31 8 (12.0%) 
Peru (43) 41 28 37 41 27 21 41 29 8 (18.6%) 
Spain (30) 23 19 20 30 26 10 27 21 4 (13.3%) 
England (66) 50 41 55 47 40 32 41 35 2 (3.03%) 
Ireland (76) 71 50 62 52 62 32 74 52 12 (15.8%) 
Africa (19) 14 14 18 18 17 15 19 8 2 (11.1%) 
Costa Rica (10) 2 3 9 8 3 1 8 5 0 (0%) 
FIG. 1. Schematic representation of the loci used for analyzing integrity of the cag-PAI in strains from eight countries. Primer sets used 
amplified eight regions, namely, LEC1 (primers LecF1/LecR1), LEC2 (primers LecF2 and LecR2), cagT (primers cagTF and cagTR), cagE 
(primers cagEF and cagER), cagA P1 (primers cagAP-F1 and cagAR2), cagA P2 (primers cagAP-F2 and cagAR2), cagA2 (primers cagAF2 and 
cagAR2), and cagAl (primers cagAF1 and cagARl). 
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FIG. 2. (A) Agarose gel electrophoresis image showing PCR amplification with strain L22 (from India) for the cag PAI regions analyzed. This 
strain was intact for all of the regions studied within the cag PAL M, 1-kb molecular size marker with corresponding base pair sizes indicated on 
the extreme right end in kilobases. (B) PCR amplification of cagT, cagE, and cagA (AF1 and AF2), the left end of cag (LF1 and LF2), and the 
promoter region of cagA (AP-F1 and AP-F2) with three randomly selected strains that either had a rearranged cag-PAI (CR 7 from Costa Rica 
[lanes 1] and P190 from northern India [lanes 3]) or completely deleted cag PAI (D185B from India [lanes 2]). Strain CR7 showed deletions in 
AP-F1, whereas strain P190 had only the cagE and LF2 regions intact. M, 100-bp molecular size marker with bands ranging from 100 to 1,000 bp. 
The corresponding PCR product sizes for cag PAI genes are summarized in Table 1. 
cag-PAI, namely, JHP520, -521, and -522 (annotated in the J99 
- genome), coding for the predicted ribose 5-phosphate isomer-
ase and a membrane protein. In addition, the promoter region 
of the cagA gene was also disrupted in the majority of the 
isolates. Within the cagA gene, deletions were more frequently 
observed involving the 3' region of the gene corresponding to 
H. pylori J99 ORF JHP0495 than at the 5' end of this ORF. A 
very high amount of nucleotide diversity has already been 
reported in this region (25). All of the results corresponding to 
rearrangement patterns of cag-PAI and the constituent genes 
are shown in Fig. 1 and 3. 
Biogeographic distribution of cag-PAI rearrangements. Our 
analyses revealed that the highest proportion of the strains 
from Japan (57.1%) were harboring an intact cag-PAI. A good 
fraction of Peruvian strains (18.6%), carried an intact cag-PAI. 
Only 12% of the 63 isolates recovered from northern, south-
ern, and western parts of India had an intact cag-PAI. Fifty 
percent of the strains from West India (Pune) were devoid of 
the entire island of genes analyzed. Three of the ten (30%) 
strains from far-northern India (Ladakh) had an intact cag-
PAI. Frequency of rearrangements in the cagA gene and the 
LEC region was higher for Indian isolates from Pune and  
Delhi than for isolates from Hyderabad and Ladakh. Conser-
vation of cag-PAI from strains in Europe and Africa was min-
imum. Majority of strains from Ireland were found to be re-
arranged except for the 15.8% strains that carried an intact 
cag-PAI. Only 2 of the 66 English strains analyzed had an 
intact cag-PAI. None of the strains from Costa Rica had intact 
cag-PAI. Strains with intermediate genotype (deletions within 
the cag-PAI) were more common compared to strains with 
intact cag-PAI in all of the geographic regions studied. cagA 
gene was present in 72.8% of strains world over while both 
cagE and cagT genes were present in 82% of these isolates, 
indicating that the presence of cagA gene alone is not a marker 
for an intact cag-PAI. Conservation of cagE region was 100% 
in Japanese and Spanish strains and lowest in Ireland. Conser-
vation of cagA promoter region was also highest among Japa-
nese strains and was lowest in Costa Rican and Indian strains. 
The LEC region was found to be more frequently rearranged 
in isolates from Costa Rica than in other isolates in the study. 
The extreme right end of the cagA gene was found to be 
frequently rearranged in all of the African isolates studied 
compared to all other isolates. However, the proximal portion 
of this gene was present in 100% of the African isolates, the 
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FIG. 3. Deletion (or rearrangement) analysis of the cag-PAI in strains belonging to eight different geographic regions. Values on y axes denote 
the percentage of strains with intactness in the genomic region analyzed. 
highest level among all of the isolates analyzed from different 
regions. In all, a total of 33.33% of the strains representing 
Asian gene pool (Japan, native Peruvian, and Ladakh) were 
intact with respect to all of the genomic landmarks analyzed. 
Conversely, only 10.25% of the strains representative of all 
other gene pools (Indo-Europe, African, and American) were 
found to be harboring an intact PM. 
Corroboration with clinical outcome. Although no associa-
tion could be discerned between the presence of cagA gene and 
the clinical outcome, the deletion frequency of both cagE and 
cagT genes was higher in nonulcer dyspepsia than in cases of 
ulcer and cancer. cagA, cagE, and cagT were found to be more 
frequently rearranged in isolates linked to rather benign infec-
tions than in isolates recovered from patients suffering from 
severe ulcers and gastric cancers worldwide. The cagA gene 
was intact in 60% of the isolates from benign cases, whereas it 
was intact in >82% of the isolates recovered from patients 
with ulcers and cancers. The cagT gene was conserved in 100 
and 80% of the isolates analyzed from cases of severe gas-
troduodenal pathology and gastritis, respectively. Conversely, 
the cagA promoter and LEC regions were rearranged more 
frequently in isolates linked to severe pathology than isolates 
responsible for a more benign outcome worldwide (Fig. 4). 
Many of the Japanese and Peruvian strains linked to nonulcer 
gastritis were also found to be intact with respect to all of the 
regions analyzed. Surprisingly, none of the five cancer strains 
from Costa Rica were found to be intact. 
DISCUSSION 
Pathogenic H. pylori may have evolved from its benign coun-
terparts by acquiring large amounts of genetic information in  
the form of PAIs that would have conferred upon it an in-
creased fitness for colonizing new host niches (19). The ancient 
circumstances associated with such acquisition and the impact 
of the same on human gastric disease epidemiology is a subject 
of intense argument. Our study sought to perform an extensive 
survey of the genetic rearrangements within the cag-PAI by 
using a large number of H. pylori strains from across the globe. 
It appears that rearrangement in cag-PAI is quite a prevalent 
phenomenon, and its constituent genes are under selection 
pressure more than any other regions in the chromosome. A 
recent study, in which paired antral and corpus isolates differed 
with respect to polymorphism of cagA locus, supports this idea 
(9). However, these paired isolates were identical with respect 
Benign infections 	 Severe (ulcers and 
cancers) 
FIG. 4. Deletion of the cag-PAI regions with respect to disease 
condition. Values on they axis denote the percentages of strains with 
intactness in the genomic region analyzed. 
a cagA 
cagE 
cagT 
D cagA promoter 
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to other important loci, such as the vacA, ribAP, vacAP, and 
cagA-glr motifs, -50 fluorescent amplified fragment length 
polymorphism loci, and many RAPD [random(ly) amplified 
polymorphic DNA] loci (9). Mechanisms underlying such re-
arrangements are unknown. Insertion elements have been re-
ported to cause rearrangements in the H. pylori genome (3, 50). 
The core sequence of the 31-bp direct repeat flanking the 
cag-PAI has sequence homology with the flanking ends of 
IS605 element (11). Insertion of the latter in functionally silent 
regions of PAIs has been reported (20, 42). Strains lacking the 
cag-PAI contained the IS605 (5, 23, 28), although its location 
within the cag-PAI could not be demonstrated. In contrast, 
certain studies have failed to identify IS605 elements within the 
cag-PAI and their association to the strains with rearranged 
genes (23, 28, 37, 47). Apart from this, one can also guess the 
involvement of certain dedicated gene products (such as DNA 
helicases), encoded by chromosomal regions flanking the cag-
PAI, in propagating the island (16). However, in our study the 
rearrangement profiles obtained for regions within the cag-PAI 
were independent of the insertion deletion and substitution 
activities (in-del-sub) involving putative helicase (hel), IS605 
and 15606 at the extreme right end of the cag-PAI (data not 
shown). These in-del-sub profiles have been previously re-
ported for a majority of isolates from our collection (10, 21, 
25). 
Genotype-phenotype correlation in case of cag-PAI geno-
types is a difficult exercise, although there are reports describ-
ing the association between the presence of the cag-PAI and 
disease type (5, 6, 34). The pathogenic role of the cag-PAI as 
a whole or in part, in disease development, is not yet com-
pletely understood (8, 12, 32, 39). H. pylori strains differing in 
virulence potentials can colonize in a mixed infection and 
emergence of recombinant strains, with deletion of cag-PAI, 
cannot be ruled out. It is therefore possible to isolate strains 
with rearranged cag-PAI from gastric ulcer and cancer pa-
tients. Isolates linked to severe pathology (including gastric 
cancers) in our study did not reveal an intact cag-PAI. In case 
of chronic infections, It is possible that strains with intact 
cag-PAI may subsequently rearrange the island long after the 
initial damage (leading to severe pathology after many years). 
On the basis of our analyses, the cag-PAI was found to be most 
intact in Japanese strains. This is in agreement with reports of 
an increased occurrence of gastric cancer and augmented se-
verity of gastric ulcers in this part of the world (27, 31, 44). 
However, it will be premature to link disease outcome to re-
arrangement patterns within cag-PAI unless a large number of 
strains with precisely defined clinico-epidemiological and 
pathological features are analyzed. Also, the cag-PAI may not 
be the principal virulence factor, as suggested by the absence 
or sporadic distribution of the cag-PAI genes among strains 
from varied clinical outcome. This may be due to the fact that 
the development of ulcer disease is a complex process that also 
involves factors other than the cag-PAI, such as the constitu-
ents of the outer membrane, vacA, and the nuclear activating 
protein, etc. Nonetheless, the PCR-based rearrangement pro-
filing described here could provide the clinician with an edu-
cated guess on the present proinflammatory power of the in-
fecting strain. This will be immensely helpful in case of patients 
colonized only with a single strain and not undergoing eradi-
cation therapy. The genotypic signatures thus developed may  
also help track the routes of infection in communities and may 
be used as reference material in the form of strain databases. 
Finally, the present study of H. pylori cag-PAI genotypes from 
different human populations adds to our understanding of bac-
terium-host interactions and the ecology of the bacterium in 
mixed infections. It will also be helpful to confirm the impor-
tance of H. pylori geographical genomics in studying gastrodu-
odenal pathology in humans. 
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